NK
Neil Kumar
Chief Executive OfficerDirector
Neil KumarChief Executive OfficerDirector
Neil Kumar insider trades: BridgeBio Pharma (BBIO) stock buys and sales
Chief Executive Officer, BridgeBio Pharma Last trade Sep 17, 2026 83 Form 4 filings
$51.7M
Sold, last 12 months
21 sales
$0
Bought, last 12 months
0 buys
66
Open-market trades
since 2018
4
Companies
last trade 2026
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Neil reports to the SEC
BBIOBridgeBio Pharma
Chief Executive Officer · last filing Sep 21, 2026
-$144.1M
BBOTBridgeBio Oncology Therapeutics
Insider · last filing Jun 18, 2026
No market trades
MAZEMaze Therapeutics
Insider · last filing Mar 31, 2026
No market trades
EIDXEidos Therapeutics
Chief Executive Officer · last filing Jul 8, 2019
+$72.0M
Open-market buys and sales
66 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | BBIO | ↓ Sell | 10,000 | $69.08 | $691K | By Kumar Haldea Family Irrevocable Trust | Sep 21, 2026 (4d) |
| Aug 19, 2026 | BBIO | ↓ Sell | 10,000 | $84.03 | $840K | By Kumar Haldea Family Irrevocable Trust | Aug 20, 2026 (1d) |
| Aug 18, 2026 | BBIO | ↓ Sell | 34,980 | $82.53 | $2.9M | Direct | Aug 20, 2026 (2d) |
| May 21, 2026 | BBIO | ↓ Sell | 26,103 | $69.44 | $1.8M | Direct | May 26, 2026 (5d) |
| May 8, 2026 | BBIO | ↓ Sell | 40,000 | $67.40 | $2.7M | By Kumar Haldea Family Irrevocable Trust | May 11, 2026 (3d) |
| May 8, 2026 | BBIO | ↓ Sell | 40,000 | $67.40 | $2.7M | By Kumar Haldea Revocable Trust, of whic | May 11, 2026 (3d) |
| Apr 10, 2026 | BBIO | ↓ Sell | 40,000 | $74.61 | $3.0M | By Kumar Haldea Family Irrevocable Trust | Apr 13, 2026 (3d) |
| Apr 10, 2026 | BBIO | ↓ Sell | 40,000 | $74.61 | $3.0M | By Kumar Haldea Revocable Trust, of whic | Apr 13, 2026 (3d) |
| Mar 13, 2026 | BBIO | ↓ Sell | 40,000 | $68.76 | $2.8M | By Kumar Haldea Revocable Trust, of whic | Mar 16, 2026 (3d) |
| Mar 13, 2026 | BBIO | ↓ Sell | 40,000 | $68.76 | $2.8M | By Kumar Haldea Family Irrevocable Trust | Mar 16, 2026 (3d) |
| Feb 19, 2026 | BBIO | ↓ Sell | 28,053 | $71.39 | $2.0M | Direct | Feb 23, 2026 (4d) |
| Feb 11, 2026 | BBIO | ↓ Sell | 40,000 | $71.86 | $2.9M | By Kumar Haldea Family Irrevocable Trust | Feb 12, 2026 (1d) |
| Feb 11, 2026 | BBIO | ↓ Sell | 40,000 | $71.86 | $2.9M | By Kumar Haldea Revocable Trust, of whic | Feb 12, 2026 (1d) |
| Jan 9, 2026 | BBIO | ↓ Sell | 40,000 | $75.54 | $3.0M | By Kumar Haldea Family Irrevocable Trust | Jan 12, 2026 (3d) |
| Jan 9, 2026 | BBIO | ↓ Sell | 40,000 | $75.54 | $3.0M | By Kumar Haldea Revocable Trust, of whic | Jan 12, 2026 (3d) |
| Dec 15, 2025 | BBIO | ↓ Sell | 30,011 | $74.64 | $2.2M | Direct | Dec 16, 2025 (1d) |
| Dec 5, 2025 | BBIO | ↓ Sell | 40,000 | $73.86 | $3.0M | By Kumar Haldea Revocable Trust, of whic | Dec 8, 2025 (3d) |
| Dec 5, 2025 | BBIO | ↓ Sell | 40,000 | $73.86 | $3.0M | By Kumar Haldea Family Irrevocable Trust | Dec 8, 2025 (3d) |
| Nov 20, 2025 | BBIO | ↓ Sell | 26,156 | $65.84 | $1.7M | Direct | Nov 24, 2025 (4d) |
| Nov 7, 2025 | BBIO | ↓ Sell | 40,000 | $62.29 | $2.5M | By Kumar Haldea Family Irrevocable Trust | Nov 10, 2025 (3d) |
| Nov 7, 2025 | BBIO | ↓ Sell | 40,000 | $62.29 | $2.5M | By Kumar Haldea Revocable Trust, of whic | Nov 10, 2025 (3d) |
| Oct 9, 2025 | BBIO | ↓ Sell | 40,000 | $54.79 | $2.2M | By Kumar Haldea Family Irrevocable Trust | Oct 10, 2025 (1d) |
| Oct 9, 2025 | BBIO | ↓ Sell | 40,000 | $54.79 | $2.2M | By Kumar Haldea Revocable Trust, of whic | Oct 10, 2025 (1d) |
| Sep 5, 2025 | BBIO | ↓ Sell | 40,000 | $52.20 | $2.1M | By Kumar Haldea Family Irrevocable Trust | Sep 8, 2025 (3d) |
| Sep 5, 2025 | BBIO | ↓ Sell | 40,000 | $52.20 | $2.1M | By Kumar Haldea Revocable Trust, of whic | Sep 8, 2025 (3d) |
| Aug 20, 2025 | BBIO | ↓ Sell | 26,156 | $48.82 | $1.3M | Direct | Aug 22, 2025 (2d) |
| Aug 8, 2025 | BBIO | ↓ Sell | 40,000 | $45.84 | $1.8M | By Kumar Haldea Revocable Trust, of whic | Aug 11, 2025 (3d) |
| Aug 8, 2025 | BBIO | ↓ Sell | 40,000 | $45.84 | $1.8M | By Kumar Haldea Family Irrevocable Trust | Aug 11, 2025 (3d) |
| Jul 2, 2025 | BBIO | ↓ Sell | 40,000 | $42.63 | $1.7M | By Kumar Haldea Family Irrevocable Trust | Jul 3, 2025 (1d) |
| Jul 2, 2025 | BBIO | ↓ Sell | 40,000 | $42.63 | $1.7M | By Kumar Haldea Revocable Trust, of whic | Jul 3, 2025 (1d) |
| May 20, 2025 | BBIO | ↓ Sell | 75,000 | $33.40 | $2.5M | By Kumar Haldea Revocable Trust, of whic | May 20, 2025 (0d) |
| May 19, 2025 | BBIO | ↓ Sell | 26,156 | $33.33 | $872K | Direct | May 20, 2025 (1d) |
| Apr 22, 2025 | BBIO | ↓ Sell | 75,000 | $34.11 | $2.6M | By Kumar Haldea Revocable Trust, of whic | Apr 24, 2025 (2d) |
| Mar 25, 2025 | BBIO | ↓ Sell | 75,000 | $36.87 | $2.8M | By Kumar Haldea Revocable Trust, of whic | Mar 27, 2025 (2d) |
| Feb 25, 2025 | BBIO | ↓ Sell | 75,000 | $33.57 | $2.5M | By Kumar Haldea Revocable Trust, of whic | Feb 27, 2025 (2d) |
| Feb 19, 2025 | BBIO | ↓ Sell | 31,543 | $36.14 | $1.1M | Direct | Feb 19, 2025 (0d) |
| Jan 29, 2025 | BBIO | ↓ Sell | 600,000 | $36.31 | $21.8M | By Kumar Haldea Revocable Trust, of whic | Jan 30, 2025 (1d) |
| Nov 19, 2024 | BBIO | ↓ Sell | 27,389 | $22.41 | $614K | Direct | Nov 20, 2024 (1d) |
| Aug 19, 2024 | BBIO | ↓ Sell | 27,389 | $24.69 | $676K | Direct | Aug 20, 2024 (1d) |
| Nov 17, 2023 | BBIO | ↓ Sell | 51,552 | $29.10 | $1.5M | Direct | Nov 20, 2023 (3d) |
| Aug 17, 2023 | BBIO | ↓ Sell | 51,552 | $28.59 | $1.5M | Direct | Aug 18, 2023 (1d) |
| May 17, 2023 | BBIO | ↓ Sell | 51,552 | $14.01 | $722K | Direct | May 18, 2023 (1d) |
| May 3, 2023 | BBIO | ↓ Sell | 120,000 | $14.18 | $1.7M | Indirect | May 5, 2023 (2d) |
| Apr 5, 2023 | BBIO | ↓ Sell | 120,000 | $15.46 | $1.9M | Indirect | Apr 7, 2023 (2d) |
| Mar 3, 2023 | BBIO | ↓ Sell | 120,000 | $10.96 | $1.3M | Indirect | Mar 3, 2023 (0d) |
| Feb 17, 2023 | BBIO | ↓ Sell | 44,798 | $12.70 | $569K | Direct | Feb 21, 2023 (4d) |
| Feb 3, 2023 | BBIO | ↓ Sell | 120,000 | $11.01 | $1.3M | Indirect | Feb 6, 2023 (3d) |
| Jan 5, 2023 | BBIO | ↓ Sell | 120,000 | $7.67 | $921K | Indirect | Jan 6, 2023 (1d) |
| Nov 17, 2022 | BBIO | ↓ Sell | 34,640 | $9.40 | $326K | Direct | Nov 18, 2022 (1d) |
| Aug 4, 2020 | BBIO | ↓ Sell | 80,000 | $27.23 | $2.2M | Indirect | Aug 5, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BBIO insiders
Open-market trades in the last 12 months
Maricel Apuli
Chief Accounting Officer
4 sales
Oct 30, 2026
Jennifer E. Cook
Director
2 sales
Jun 24, 2026
Hannah Valantine
Director
4 sales
Jun 23, 2026
Thomas Trimarchi
President and CFO
3 sales
May 18, 2026
Randal W. Scott
Director
3 sales
May 15, 2026
Andrea Ellis
Director
1 sale
Mar 4, 2026
Andrew Lo
Director
1 sale
Nov 18, 2025
About Neil Kumar's insider trades
Neil Kumar is Chief Executive Officer at BridgeBio Pharma (BBIO). Since Jun 22, 2018, Neil has reported 3 open-market purchases worth $72.0M and 63 sales worth $144.1M on SEC Form 4. In the last 12 months: 21 sales ($51.7M).
Their filings also include option exercises (28 filings), shares withheld for taxes (27 filings), grants and awards (11 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.